Abstract
Diabetic complications in the lower extremity are associated with significant morbidity and mortality, and impact heavily upon the public health system. Early and accurate recognition of these abnormalities is crucial, enabling the early initiation of treatments and thus avoiding or minimizing deformity, dysfunction and amputation. Following careful clinical assessment, radiological imaging is central to the diagnostic and follow-up process. We aim to provide a comprehensive review of diabetic lower limb complications designed to assist radiologists and to contribute to better outcomes for these patients.
INTRODUCTION
Diabetic complications in the lower extremity are common and diverse. They are associated with significant morbidity and mortality and impact heavily upon the public health system. These complications result from complex interactions between diabetic vasculopathy, neuropathy, structural deformity and decreased immunity. Early and accurate recognition of these abnormalities is crucial, enabling the early initiation of treatments and thus avoiding or minimizing later complications. Following careful clinical assessment, radiological imaging is central to the diagnostic process. Unfortunately, most radiologists are relatively unfamiliar with the complex interplay of disease processes in this patient cohort. Furthermore, most do not have the opportunity to work closely with a dedicated team of clinical specialists (podiatrists, endocrinologists and vascular surgeons) in a multidisciplinary forum (at Monash Health, this is called the High Risk Diabetic Foot Unit) where valuable feedback, follow-up and clinical insights are provided. As a consequence, radiographs, CT and MRI of abnormal diabetic lower limbs are not infrequently misinterpreted, and sometimes, important findings are simply missed. We aim to provide a comprehensive review of lower limb complications in diabetes mellitus designed to assist radiologists and to contribute to better outcomes for these patients. Topics are grouped anatomically rather than pathologically owing to the multifactorial nature of their aetiologies.
PERIPHERAL ARTERIES
Diabetes mellitus contributes significantly and independently to the development of peripheral arterial disease and is associated with a 4–5 times increased likelihood of critical limb ischaemia and lower limb amputation.1–3 Peripheral artery disease delays ulcer healing and predisposes to gangrene formation, as the diminished arterial supply is incapable of meeting the increased metabolic demand of an infected foot.4,5 Lower limb atherosclerosis in patients with diabetes tends to occur more distally.3,6,7 Arteries below the knee are preferentially affected, particularly the peroneal and posterior tibial arteries. Aortoiliac disease is usually less severe.6 Common to all imaging modalities, appearances of atherosclerotic lesions include calcific or non-calcific plaques, stenoses and occlusions.8 Diabetes-related peripheral artery disease may also display characteristic microaneurysms and tortuosity in distal arteries.6
Digital subtraction angiography (DSA) is the gold standard in diagnosing the extent and severity of peripheral artery disease and provides potential for angiographic interventions (Figure 1). Relative disadvantages include it being invasive and relatively poor characterization of focal lesions with complex morphology when compared with cross-sectional imaging techniques such as multiple detector CT.9,10
Figure 1.
Lower limb angiography and angioplasty. Unsubtracted images (a, c) from a selective right lower limb digital subtraction angiogram in a 54-year-old male with ischaemic tissue loss of the great toe. Figure (a) reveals diffuse disease with multiple moderate- to high-grade stenoses of the anterior tibial artery (arrow), proximal occlusion of the peroneal artery (right-pointing arrow head) and multifocal stenosis and distal occlusion of the posterior tibial artery (left-pointing arrow head), a typical distribution of peripheral vascular disease in diabetes. Digital subtraction image of angioplasty to treat the diseased anterior tibial artery (b), and post-angioplasty result showing improved vessel calibre and flow (c).
Non-invasive techniques such as duplex ultrasound, CT angiography and MR angiography are increasingly used to assess diabetic peripheral artery disease and guide the choice of subsequent intervention (e.g. endovascular vs surgery). Duplex ultrasound is now in many places the first-line imaging modality for investigation of peripheral artery disease with reported sensitivity and specificity of 87.6% and 94.7%, respectively.11 The accuracy of this modality does however remain variable as there is significant operator dependence. MR angiography and CT angiography have also been compared reasonably with conventional DSA, but both techniques suffer from reduced spatial resolution and accuracy in the smaller, peripheral arteries.11–16
Other than clinical assessment and ankle–brachial index measurement, duplex ultrasound is routinely used as the first-line modality at our institution. The standard of arterial ultrasound in our Diagnostic Imaging Department is high, and the results are consistent with findings at DSA, if performed. Not infrequently, dense arterial calcification or excessive subcutaneous fat in the lower abdominal area preclude accurate duplex ultrasound assessment of the crural arteries and iliac arteries, respectively. In these instances, CT angiography or DSA is used, the latter especially if endovascular treatment is being contemplated.
NERVES
Playing a pivotal role in the pathogenesis of diabetic foot complications, diabetic neuropathy is usually diagnosed on clinical grounds, augmented by electrophysiological studies. Diffuse symmetrical sensorimotor polyneuropathy is the commonest presentation, followed by focal or multifocal neuropathies.17 Diabetic amyotrophy results from lumbosacral plexopathy and manifests as thigh pain and progressive weakness. Muscular atrophy may be evident on cross-sectional imaging.17–19 MR neurography has been increasingly tested in experimental studies to diagnose peripheral neuropathy. Using 3.0-T MRI systems, diseased nerves may display the following features: (1) fusiform enlargement, (2) increased signal on fluid sensitive sequences (T2 signal), (3) abnormal fascicular pattern, (4) deviated course and (5) enhancement with contrast.20–22 Symmetrical multifocal intraneural lesions in proximal nerves of lower limb have been recently described using MR neurography, correlating with more severe neuropathic symptoms.23
SOFT TISSUES
Fat atrophy
Fatty involution is common (Figure 2). Ultrasound studies of long-term patients with diabetes have demonstrated thinned plantar soft tissue in the region of the metatarsal heads, and correlative MRI has confirmed the fibrous replacement of fat in this area.24 Atrophied and displaced plantar fat pads provide less protection against microtrauma, leading to ulcerations.25,26
Figure 2.
MRI of the foot. Sagittal T1 of the forefoot in a 49-year-old male with Type 1 diabetes mellitus showing marked thinning of the protective “fat pad” overlying the first metatarsal head (arrow). In an ambulating patient, this predisposes to ulceration, infection and osteomyelitis, especially in the context of peripheral neuropathy.
Callus and ulceration
Callus formation and skin ulceration are seen in a significant number of patients with diabetes in predictable locations vulnerable to increased pressure and friction. The typical sites are over the distal great toe, heads of first and fifth metatarsals, posterior calcaneus, medial and lateral malleoli.27 The plantar soft tissues superficial to the cuboid are particularly susceptible in patients with the “rocker-bottom” deformity as part of Charcot neuropathic osteoarthropathy (CN).28,29 Callus predisposes to ulceration, which predisposes to cellulitis and osteomyelitis.30,31
On MRI, calluses appear as well-defined focal prominence overlying skin and subcutaneous tissue. They can demonstrate T1 hypointense, T2 hypointense or isointense signal, with significant gadolinium contrast enhancement except where there is devitalized soft tissue.32 Ulcerations are seen on MRI as defects of skin and/or subcutaneous tissue and, if formed on previous calluses, surrounded by “heaped-up” edges (Figure 3). The base of the ulcer contains granulation tissue.27
Figure 3.
MRI of the foot. Axial T2 fat-suppressed (a) and sagittal T1 (b) weighted images demonstrate a deep penetrating skin ulcer on the plantar medial aspect of the calcaneum and sinus tract (arrows) with a “tram-track” appearance. The presence of a deep infected ulcer and sinus tract, and associated adjacent bone marrow oedema (asterisk) is highly specific for established osteomyelitis.
Sinus tracts
Sinus tract allows a portal for dermal organisms to enter and infect deep soft tissue or bone. The course of the sinus tract, if able to be traced on MRI may point to site(s) of osteomyelitis. Sinus tracts most often appear as thin linear soft-tissue T2 hyperintense signal with enhancing margins on post-gadolinium chelate fat-suppressed T1 imaging, giving the typical “tram-track” appearance (Figure 3).33,34
Cellulitis
Soft-tissue infection often results from contiguous spread of microorganisms via skin ulcerations and sinus tracts. Plain radiograph and CT might show swelling, loss of fascial planes and occasionally gas within soft tissues.35 Gas is encountered in cellulitis secondary to gas-forming organisms or, more commonly, air tracking from skin ulceration to deeper tissues.8 MRI features of cellulitis include thickened skin, subcutaneous oedema, increased fat reticulation and alteration of the normal fat signal. Cellulitic fat appears hypointense relative to normal fat on T1 weighted images and hyperintense to muscle on fat-suppressed T2 weighted images (Figure 4).32 The presence of intense contrast enhancement is useful in differentiating true cellulitis from benign soft-tissue oedema, also seen commonly in the diabetic foot.32 It is important to note, however, that neither sterile devitalized tissue nor the centre of a soft-tissue abscess will enhance even in the context of regional cellulitis.8
Figure 4.
MRI of the forefoot. Axial images demonstrating soft-tissue oedema on the lateral second toe with T1 hypointensity (a, asterisk), T2 hyperintensity (b, arrow) and contrast enhancement (c, arrow head), consistent with cellulitis.
Abscess
Prolonged foot infection is often associated with abscess formation, the prevalence on MRI having been reported from 10% to 50% in patients with diabetes.36 The majority of abscesses form near skin ulcerations or sinus tracts; however, some can be seen more remotely as infection spreads to deeper tissues.37 They are found more frequently in patients with established osteomyelitis, reflecting the fact that both entities represent advanced stages of infection.36 The necrotic centre may show gas and air-fluid levels on plain radiography, hypoattenuation on contrast-enhanced CT with rim enhancement, and well-defined hypoechoic fluid collection on ultrasound, within which hyperechoic foci of debris/gas may be seen.38 Colour Doppler ultrasound demonstrates peripheral hypervascularity but no flow within the necrotic centre.38 MRI features of an established soft-tissue abscess are (1) isointensity or hypointensity relative to muscle on T1 weighted images, (2) fluid-like signal on T2 weighted images and (3) rim enhancement after intravenous gadolinium on T1 images.4
Necrotizing fasciitis
Necrotizing fasciitis is a life-threatening infection of the superficial and deep fascia diagnosed clinically. Imaging shows gas tracking along fascial planes with occasional muscle involvement.38 Rarely, the process involves adjacent bone (Figure 5).39
Figure 5.
CT of the foot. Axial CT of the foot shows extensive subcutaneous emphysema (arrows) consistent with necrotising fasciitis. In this rare case, gas extends to the mid-foot bones, indicating emphysematous osteomyelitis.
Soft-tissue hypoperfusion/ischaemia/gangrene
Microvascular disease and its associated pedal ischaemia or gangrene can be qualitatively assessed using contrast-enhanced MR angiography. Normal soft-tissue perfusion should result in contrast enhancement with at least 10% increase in signal.8 Mild ischaemia without devitalization shows subtle decrease in enhancement compared with adjacent tissue, whereas necrotic or gangrenous region shows no contrast enhancement, being sharply demarcated from surrounding rim of enhancing hyperaemic soft tissue.8 Although not utilized at our institution, dynamic MRI can also be used to quantify loss of tissue perfusion.40 Gas gangrene, caused by gas-forming bacterial infection of necrotic tissue, shows gas within soft tissue appearing as signal void on MRI.4,41 Gas gangrene is an emergency and needs to be differentiated from gas tracking from superficial ulcers to deeper tissues via sinus tracts.41
Bursitis
Immunocompromise resulting from diabetes predisposes to septic bursitis often with preceding repetitive trauma.42,43 Prepatellar bursitis is the commonest in the lower limb.44,45 Plantar ulcers or cellulitis can lead to intermetatarsal bursitis, although fluid in the first three intermetatarsal bursae can be physiological up to 3 mm in transverse diameter, as well as being seen in the development of Morton's neuroma.46 Adventitial bursitis frequently accompanies a callus as an elongated fluid collection in the adjacent subcutaneous tissue.8 Pes anserine bursitis has also been linked to diabetes, and imaging appearances are similar between infectious and inflammatory types.47–49 Ultrasound demonstrates increased synovial fluid with thickening and distension of the synovial membrane and synovial hyperaemia on colour Doppler. Bursal fluid shows heterogeneous echogenicity, often containing echogenic debris.50 MRI shows increased synovial fluid with contrast enhancement of synovial membrane but not the bursal fluid.38
Foreign bodies
Foreign bodies are commonly found in neuropathic foot owing to sensory loss and diminished protective reflexes. Impacted foreign bodies in the diabetic foot predispose to infection.32,51 Plain radiography and/or ultrasound performed with high frequency linear probes are commonly used to detect and assist with removal of foreign bodies (Figure 6). These are usually hyperechoic on ultrasound with a surrounding rim of hypoechoic inflammatory and granulomatous tissue.52,53 MRI can demonstrate low signal intensity foci, sometimes with susceptibility artefact.32
Figure 6.
Soft tissue ultrasound and foot plain X-ray. (a) A foreign body shown on ultrasound as a hyperechoic focus with ring of hypoechoic granulation tissue (arrow). (b) The same nail was seen on plain X-ray.
BONES
Osteomyelitis
Osteomyelitis in a diabetic foot or ankle is nearly always owing to contiguous spread from an adjacent ulcer or soft-tissue infection; therefore rarely found in a foot with intact skin.8 Early diagnosis is challenging, but crucial to avoid late complications such as lower limb amputation.41
Plain radiographs can demonstrate periosteal reaction, cortical destruction, loss of normal trabecular pattern and bone lysis with or without osteosclerosis (Figure 7). However, these classical signs typically do not appear until at least 7–10 days after onset of infection, when the affected bone has undergone demineralization to the order of 30–50%; enough to manifest as focal lucency.54 In early stages of infection, soft-tissue swelling and blurred fascial planes may be the only visible radiographic abnormalities likely to be detectable on plain films.54 These plain radiographic changes reflect cellulitis and should not be regarded as adequate in the exclusion of complicating osteomyelitis.
Figure 7.
Plain X-ray of the foot. Plain radiograph shows marked reduction of density and ill-defined margins in the third toe (asterisk), indicating osteomyelitis. Abnormality in the fourth toe (arrow) was longstanding and more consistent with chronic microtrauma and remodelling in the context of profound sensory neuropathy. Note previous amputation of the second metatarsal head.
CT is significantly more sensitive in demonstrating early changes of osteomyelitis compared with plain radiography. Early, in the acute phase, CT may demonstrate patchy medullary lucency, cortical destruction and periosteal reaction. In chronic osteomyelitis, sequestra and cloacae are reliably depicted by CT (Figure 8). CT contrast resolution of soft tissue detail is only modest in the detection of associated soft-tissue processes, such as cellulitis, ulcers and sinus tracts.54
Figure 8.
CT of the foot. Axial (a) and sagittal (b) views demonstrate marked osteolysis and periarticular erosive changes at the talonavicular joint with sequestrum (arrows) within the navicular, consistent with septic arthritis/osteomyelitis. Advanced Charcot foot with rocker-bottom deformity is seen, with the cuboid (b, asterisk) descended from the collapsed longitudinal arch.
Technetium triple phase bone scan has excellent sensitivity (100% in some studies) in detecting osteomyelitis, but poor specificity, particularly in patients with pre-existing Charcot foot or concomitant fractures.55 In established osteomyelitis, increased uptake is present in all three phases. Labelled leukocyte scintigraphy has been shown to improve diagnostic accuracy,55,56 particularly when combined with technetium bone scan (sensitivity, 92.6%; specificity, 97.6%).57 Concordance of positive findings on both studies indicate true osteomyelitis, while positive leukocyte scan with negative bone scan suggests possible soft-tissue infection without osseous involvement.58
MRI provides excellent detection and characterization of soft-tissue abnormalities (such as sinus tract, cellulitis and abscess) in cases of suspected osteomyelitis, with sensitivity and specificity of 90% and 79.0–82.5%, respectively.55,56 Primary signs of osteomyelitis on MRI include hypointensity of involved bone marrow on T1 weighted, hyperintensity on T2 weighted and enhancement on post-gadolinium images (Figure 9). Increased marrow signal seen on fluid sensitive or post-contrast images represents non-specific oedema and increased vascularity, therefore, can also be seen in other conditions causing local inflammation, such as CN, septic arthritis, and occasionally, intense adjacent cellulitis without established osteomyelitis. Low marrow signal on T1 weighted images reflects true alteration of normal marrow fat content; hence, it is more specific for osteomyelitis.54,55
Figure 9.
MRI of the foot. Axial views demonstrating extensive low T1 signal (a) and (b) high signal on fat-suppressed (FS) T2 weighted images. Gadolinium enhancement on axial FS T1 image (c) within the marrow of the fifth metatarsal (arrows), representing osteomyelitis, and surrounding cellulitis.
Bone infarction
Avascular necrosis (AVN) of pedal bones is a well-recognized complication in diabetes mellitus, with the talus, navicular, first and second metatarsals being the commonest sites.59 Diabetes has been linked as a risk factor for Freiberg's disease, i.e. AVN of the second metatarsal head (Figure 10).60 Radiographic signs occur late, classically showing mixed lucencies and sclerosis with the late characteristic “crescent sign”, i.e. a thin linear lucency in the subchondral area, reflecting fractured and collapsed subchondral trabeculae.61 Depending on the phase of osteonecrosis, plain radiograph and CT may be normal (acute phase) or may reveal variable amounts of osteopenia, focal bony sclerosis, mixed sclerosis and lucency (mottling), and subsequent articular collapse and fragmentation (subacute and chronic phases).62 MRI can identify early AVN prior to CT/radiographic changes or indeed clinical symptoms, particularly in the neuropathic diabetic foot.63 The infarcted medullary bone of inhomogeneous signal intensity is classically surrounded by an inner hyperintense and outer hypointense “double-line” on T2 weighted images, representing vascular granulomatous tissue underneath sclerotic bone (Figure 11).63–66 The “double-line” sign is, however, frequently absent in small pedal bones, in which poorly defined areas of T1 hypointensity may be seen without contrast enhancement.67
Figure 10.
X-ray of the foot. Previous partial amputation of the proximal phalanx of the left (L) great toe. Flattening of the heads of the left second and third metatarsals consistent with Freiberg's avascular necrosis. In addition, there are stress fractures involving the shaft of the second and third metatarsals, likely related to osteonecrosis of the metatarsal heads and amputation of the proximal phalanx of the first toe with resultant alteration in biomechanics.
Figure 11.
MRI of the lower limb. T2 fat-saturated sagittal view (a) demonstrates a serpiginous rim of T2 hyperintensity (short white arrow) in the distal tibial marrow, with central inhomogeneous T2 hypointensity (asterisk). Proton density axial view (b) shows the same lesion with hypointense rim (black arrow) and hyperintense centre. Features consistent with marrow infarction. Swelling and hyperintensity in the distal peroneus brevis muscle belly is suggestive of diabetic (ischaemic) myopathy or sterile myositis (b, long white arrow).
Pathological fractures
Pathological fractures occur in diabetes owing to the combined effects of neuropathy, vasculopathy and reduced bone quality.68,69 Bone bruises and bone oedema are visible on MRI as areas of regional altered marrow signal (dark on T1 and bright on T2 weighted images relative to normal fatty marrow). Subtle fractures that may be radiographically occult are often well seen on CT or MRI (Figure 12).70 Cuboid fractures are common and contribute to the loss of lateral pedal arch and subsequent rocker-bottom deformity.71 Atraumatic calcaneal avulsion fractures are characteristically seen in the diabetic foot. These present in three different patterns: (1) superiorly displaced posterior calcaneal avulsion, (2) impaction of mid-calcaneus, (3) “wedge type” fracture with the fracture line extending from the posterior tubercle towards the talocalcaneal joint.72 The third type is typical in patients with heel ulcer and possible underlying osteomyelitis, resulting from increased Achilles traction on the weakened calcaneum (Figure 13).73
Figure 12.
MRI of the foot. Axial short tau inversion recovery (STIR) sequence (a) and sagittal STIR sequence (b) show a non-displaced vertically orientated cuboid fracture (white arrow), with surrounding marrow oedema (asterisk). A subcortical fracture is seen at the talar dome (arrow head).
Figure 13.
X-ray of the foot. A heel ulcer with dressing is seen. Wedge shaped avulsion fracture (arrow) at the posterior calcaneum is consistent with the likely weakened bone owing to osteomyelitis and excessive traction from the Achilles tendon during ambulation.
Skeletal deformities
Common structural deformities in diabetics include hammer/claw toes, hallux valgus, pes planus and rocker-bottom deformity detectable on plain radiographs or CT.74 Hammer toe deformity (Figure 14), i.e. fixed hyperextension of metatarsophalangeal joints is thought to result from intrinsic muscle atrophy. This deformity is associated with an increased incidence of plantar skin ulceration.24,75,76
Figure 14.
X-ray of the foot. “Hammer-toe” deformity—fixed extension deformity of proximal interphalangeal joints.
JOINTS
Charcot neuropathic osteoarthropathy
CN or Charcot foot is a progressive disease affecting the joints, bones and soft tissue, especially of the foot and ankle. It is seen in up to 13% of patients with diabetes.77 Its pathogenesis is thought to stem from a combination of peripheral sensory (especially proprioceptive and pain) and autonomic neuropathy. The sensory deficits contribute to repetitive minor trauma to relatively insensitive feet whilst the autonomic deficit results in peripheral vasodilation and increased regional blood flow, which in turn results in increased osteoclastic activity. Consequent osteolysis and osteopenia predispose patients to injury thus forming a vicious cycle, leading to severe deformity.78,79 CN may mimic osteomyelitis in its acute presentation, the diagnosis of which is frequently missed or delayed in up to 25% of patients with diabetes.80–82 Identifying acute CN as an acutely swollen, erythematous and warm foot is of paramount importance, as its treatment (immediate off-loading) differs from that for infection. Delayed detection and continued ambulation and weight bearing contribute to significant irreversible deformity and subsequent disability.78 Anatomically, Charcot foot most commonly affects the mid-foot joints, i.e. tarsometatarsal (Lisfranc's), naviculocuneiform, talonavicular and calcaneocuboid joints (Chopart's).83–85
The radiographic appearance of CN can be classified into three stages.86 Stage 1 (development) demonstrates bony fragmentation with resultant debris at the articular margins, joint capsular distension and joint dislocation. Stage 2 (coalescence) shows organization of previously formed debris and fragments with osteosclerosis at bony ends. Stage 3 (reconstruction) is characterized by new bone formation, reduced osteosclerosis, rounding of bony ends and permanent deformity.86 In particular, subluxation or dislocation of Chopart's joint causes mid-foot collapse, leading to a “rocker-bottom” deformity (Figure 8). Angle analysis on lateral plain film demonstrates reduced calcaneal inclination and talar-first metatarsal misalignment. The cuboid bone becomes the weight-bearing tarsal bone increasing the susceptibility for ulceration of the overlying skin.41 Other radiographic findings include osteopenia—exaggerated by disuse from pain or deformity—osteophytosis, periosteal reaction and subchondral geode cyst formation. Monckeberg's sclerosis is also present radiographically in 78–90% of patients with diabetes with neuropathy, manifesting as radio-opaque parallel lines (when viewed in profile), representing calcified vessel walls.87,88 The cause of this phenomenon is postulated to arise from a common proinflammatory cytokine system, receptor activator of nuclear factor-kappa B ligand and osteoprotegerin (RANKL/OPG) shared in the pathogenesis of Charcot foot.89
In early Charcot (where there is a typical clinical picture, i.e. Stage 0),90 plain radiography may be normal, whilst triple phase bone scan may demonstrate increased uptake, indicating abnormal bone turn over.78 CT can show minor intra-articular fractures in addition to the typical radiographic findings.86,91 MRI is more sensitive in demonstrating early articular and soft-tissue changes,92 such as joint effusion, subluxation, articular surface erosion, periarticular soft-tissue oedema and marrow signal changes (Figure 15).93
Figure 15.
MRI of the foot. Fat-suppressed T2 axial sequence demonstrates subtle mid-foot periarticular marrow signal changes (arrows), soft-tissue oedema (right-pointing arrow head), multiple small volume joint effusions (left-pointing arrow head) and reactive tenosynovitis consistent with early Charcot neuropathic osteoarthropathy.
Charcot foot vs osteomyelitis
Differentiating acute early stage CN from osteomyelitis presents a difficult and important challenge. Clinically, acute CN and acute osteomyelitis may present with acutely inflamed extremities with warmth and swelling. There is frequently a “culprit” underlying penetrating ulcer, which the astute clinician (in our High Risk Diabetic Foot unit, the subspecialty podiatrist) will gently attempt to “probe to bone”—a clinical technique consisting of exploring the wound for palpable bone with a sterile blunt metal probe.94 In the context of an infected ulcer, a positive “probe to bone” result is highly specific for osteomyelitis.95
Important radiological clues for osteomyelitis include the anatomical location, presence of deep adjacent ulcers and sinus tracts, and the pattern of marrow abnormality on MRI. Marrow signal abnormality in multiple mid-foot joints, confined to the subchondral bone but affecting both articular ends within a joint, with no evidence of adjacent skin ulcers or connecting sinus tracts, is more likely to represent an acute Charcot foot. True osteomyelitis commonly involves a single bone of the forefoot or the posterior calcaneus, directly deep to an ulcer, with more diffuse marrow signal abnormality.37 As CN progresses into the coalescent or reconstruction stage, more permanent deformities and less marrow signal abnormality is observed, usually allowing easier differentiation between the two entities.34,37 This may, however, be confounded by new or persisting marrow signal abnormalities, particularly in the ambulating patient—the result of an abnormal stress response owing to altered biomechanics.
Charcot foot complicated by infection
Osteomyelitis superimposed on a pre-existing Charcot foot adds further diagnostic difficulty. MRI signs more closely correlated with infection include large soft-tissue fluid collection, diffuse and profound marrow abnormality, soft-tissue fat signal change and direct relationship with a sinus tract or skin ulcer. Subchondral cysts and intra-articular loose bodies, if present, favour a diagnosis of established CN.93 The “ghost sign” has been proposed as a useful and reasonably specific sign to detect true superimposed infection in the neuropathic foot (Figure 16). In the case of established infection, increased water content within the marrow (infection related oedema) results in the affected bone(s) being rendered dark and thus poorly seen against a background of T1-dark skeletal muscle and T1-dark oedematous fat on T1 weighted sequences.96 These infected bones are well seen as having abnormally bright, and enhancing marrow on fat-suppressed T2, and post-gadolinium contrast-enhanced fat-suppressed T1 imaging. This phenomenon of ghosting is not seen on MRI in the aseptic neuropathic foot.96
Figure 16.
MRI of the foot. Mid-foot structures in sagittal views were poorly defined on T1 images (a), but regained their structural clarity on T2 images (b and c) after intravenous gadolinium injection. This “ghost sign” suggests Charcot foot with superimposed osteomyelitis.
Septic arthritis
Similar to cellulitis and osteomyelitis in the diabetic foot, septic arthritis commonly results from direct inoculation from adjacent skin ulceration. Frequently involved joints in the foot and ankle closely correlate with sites of ulceration, with the interphalangeal and metatarsophalangeal joints being the most common locations (Figure 17).27,97,98 Mid-foot involvement is seen in patients with Charcot foot, particularly when “rocker-bottom” deformity is present. Posterior calcaneal ulcers tend to spread to the ankle or subtalar joints.41 No single MR sign is pathognomonic for this diagnosis, but large joint effusions, intense synovial enhancement and perisynovial oedema are considered suggestive of a septic joint.97 Septic arthritis can mimic mid-foot CN on MRI. Subchondral marrow oedema associated with septic arthritis demonstrates hyperintensity on T2 weighted images, but the same may be seen in both Charcot foot and osteomyelitis. Generally in septic arthritis marrow signal abnormality is localized to subarticular bone, but superimposed osteomyelitis may result in more diffuse abnormal marrow signal beyond subchondral bone.34
Figure 17.
MRI of the foot. Abnormal T2 marrow hyperintensity (arrows) is seen in the periarticular region of the medial part of first metatarsophalangeal joint. The profound joint space loss and presence of adjacent infected skin ulcer (asterisk) further suggests septic arthritis.
MUSCLES
Muscle atrophy
Motor neuropathy in diabetes causes striated muscle atrophy, typically affecting the distal pedal muscles first.99,100 The degree of atrophy can be assessed on CT or MRI by analysing the muscle volume and morphology, with significant fat replacement of atrophic muscle seen in advanced cases.32,101
Diabetic myopathy
First described and termed in 1965 by Angervall and Stener102 as “tumoriform focal muscular degeneration”, this uncommon entity has been reported in the literature as diabetic muscle infarction or myonecrosis. Its occurrence reflects poor diabetic control with extensive atherosclerosis, microangiopathy and possibly underlying coagulopathy.103 Diabetic myopathy was traditionally described in patients with Type 1 diabetes only but is increasingly seen in patients with Type 2 diabetes especially those requiring insulin.104 The typical presentation is that of acute onset of pain and swelling in affected muscles, often bilateral, occasionally with a palpable mass. Importantly, systemic symptoms are unusual. The thigh muscles are the most commonly affected, followed by calf and short rotators of the hip.105 Imaging, especially MRI (Figure 18), is useful in the diagnosis of this condition and thus helps to avoid unnecessary biopsies and surgical intervention. In most patients, diabetic myopathy will resolve spontaneously following conservative management.
Figure 18.
Lower limb MRI. (a) Marked T2 hyperintensity is seen in muscles of the adductor compartment (black asterisks). On T1 images (b), rim enhancement (white arrows) with central hypointensity (white asterisks) in the same areas is seen, consistent with diabetes myonecrosis. (c) A pocket of sterile fluid (found at surgical drainage) is also seen (black arrow). 6-month follow-up MRI (d) showing marked muscle atrophy in the affected muscle groups.
In cases of acute diabetic myopathy/myonecrosis, MRI demonstrates muscle oedema, with T1 hypointensity or isointensity. T1 hyperintensity is observed in patients with intramuscular haemorrhage.106 On T2 weighted images, affected muscles show corresponding hyperintensity owing to oedema and inflammation. On post-contrast T1 images, peripherally enhancing, centrally hypointense areas of muscle represent areas of necrosis, indistinguishable from intramuscular abscess.107 Additional MRI findings include subcutaneous oedema, subfascial fluid and obliteration of fatty intermuscular septa. On MRI, the differential diagnoses of diabetic myopathy are pyomyositis/abscess, necrotizing fasciitis, acute denervation atrophy of muscle and other non-infective/incidental causes of myositis.104
MRI features of diabetic myonecrosis, tumour with necrotic centre and abscess may overlap. Ultrasound may help further differentiate diabetic myonecrosis from the other entities by demonstrating (1) the absence of a typical abscess such as anechoic centre, (2) hyperechoic lines within the lesion representing muscle fibres and (3) lack of fluid-like motion when applying probe pressure.108
Pyomyositis
Bacterial infection of skeletal muscle is rare owing to its rich vascular supply. Being mostly a tropical disease, its occurrences in temperate regions are usually associated with trauma or immunocompromise, diabetes being a major risk factor.109,110 Oedematous muscle appears on ultrasound as poorly defined hypoechogenicity, whilst on CT as regions of slight hypoattenuation. MRI is much more sensitive and demonstrates muscle enlargement, initial iso–hypointensity on T1 weighted and hyperintensity on fluid sensitive sequences (Figure 19). As the disease progresses to necrosis and liquefaction, typical features of abscess common to other body regions can be seen, as discussed previously. Contrast-enhanced imaging shows variable enhancement of the affected muscle with non-enhancement of devitalized muscle or pus at the centre of the abscess if present.38,50,111
Figure 19.
MRI of the pelvis. T1 weighted fat-suppressed sequence with intravenous gadolinium in coronal (a) and axial (b) views demonstrate a lobulated fluid collection (asterisk) within a diffusely abnormal right iliacus muscle consistent with pyomyositis and abscess formation. Fluid is also seen in the right sacroiliac joint (arrow), indicating septic arthritis.
TENDONS
Tendinopathy
Studies suggest a link between diabetes and tendon disorders.112 Achilles and plantar fascia thickening have been demonstrated using CT, MRI and ultrasound113–115 and are associated with increased pedal tensile force and altered gait biomechanics.116 Tibialis posterior and flexor hallucis longus dysfunction contribute to flatfoot deformity. The spectrum of tendon abnormalities range from peritenonitis/paratenonitis to tendinosis, tendon tears and rupture. On ultrasound, paratenonitis/peritenonitis displays loss of normal paratenon hyperechogenicity with synovial fluid accumulation. Tendinosis demonstrates intratendinous ill-defined hyperechogenicity, disorganized fibres, increased thickness and calcifications. Partial or complete tendon tear shows well-defined hypoechoic cleft that extends to tendon surface.117 MRI findings include paratendinous T2 hyperintensity, intratendinous hyperintensity on both T1 and T2 weighted images and loss of fibre continuity with hyperintense gaps in ruptured or fully torn tendons.67,118,119
Septic tenosynovitis
Tenosynovitis can occur in the presence of skin ulceration, cellulitis or osteomyelitis. The most commonly involved are the peroneal, Achilles and plantar flexor tendons (Figure 20) owing to their close proximity to the lateral malleolus, calcaneus and weight-bearing bones on plantar surface of the foot.41,120 MRI features include presence of peritendinous fluid as hyperintense signals on T2 weighted sequence, thickened tendon and post-contrast synovial enhancement, suggesting increased vascularity and inflammation.41,120 If MRI signs are seen in conjunction with directly adjacent skin ulceration and soft-tissue infection, septic tenosynovitis is very likely.34 Where MRI is not readily available, high-resolution ultrasound and power Doppler can demonstrate synovial thickening ± peritendinous fluid, with synovial hyperaemia seen on colour Doppler.50
Figure 20.
MRI of the foot. Contrast-enhanced T1 weighted fat-suppressed coronal image demonstrates marked swelling and contrast enhancement of the flexor hallucis longus tendon at the level of the metatarsals (arrow), indicating infective tendonitis and tenosynovitis.
CONCLUSION
A multidisciplinary approach to the “high-risk diabetic foot”, in our experience, has proven to be very effective in managing complications in this ever increasing cohort of patients specifically in reducing morbidity, including limb loss, as well as length of stay in hospital. As discussed, diabetes has broad spectrum of manifestations in the lower limb. Timely, combined expert input from dedicated podiatrists, endocrinologists, vascular surgeons and radiologists in this forum has proven to be a very successful model, resulting in early diagnosis of complications and the subsequent ability to expedite aggressive treatment.
Multiple imaging modalities are employed as appropriate, with increased reliance on high-resolution MRI, specifically to confirm or exclude the presence of early neuropathic osteoarthropathy, devitalized soft tissue or bone, septic arthritis, osteomyelitis and soft-tissue abscesses. The role of the radiologist is central in terms of providing accurate and early diagnosis of complications, as well as monitoring the progress of complications and treatment. Radiologists are also uniquely placed to advise on, and perform specific image-guided interventions such as lower limb arterial revascularization procedures for ischaemia, joint aspiration for suspected septic arthritis, bone biopsy for suspected osteomyelitis, as well as percutaneous drainage of soft-tissue abscesses.
In the experience of the authors, general radiologists perform interpretation of imaging of complications of the diabetic foot very variably. It is our hope that this review, incorporating perspectives from radiologists who work closely as part of a large multidisciplinary “high-risk diabetic foot team”, will substantially contribute to the body of knowledge on this topic and assist radiologists to provide a higher quality of service to this important and growing cohort of patients.
Contributor Information
P Naidoo, Email: parm.naidoo@gmail.com.
V J Liu, Email: liujinvictory@gmail.com.
M Mautone, Email: marcelapm@hotmail.com.
S Bergin, Email: shan.bergin@monashhealth.org.
REFERENCES
- 1.Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24: 1433–7. doi: 10.2337/diacare.24.8.1433 [DOI] [PubMed] [Google Scholar]
- 2.Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006; 47: 921–9. doi: 10.1016/j.jacc.2005.09.065 [DOI] [PubMed] [Google Scholar]
- 3.van der Feen C, Neijens FS, Kanters SD, Mali WP, Stolk RP, Banga JD. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med 2002; 19: 366–70. doi: 10.1046/j.1464-5491.2002.00642.x [DOI] [PubMed] [Google Scholar]
- 4.Ledermann HP, Schweitzer ME, Morrison WB. Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess. AJR Am J Roentgenol 2002; 178: 215–22. doi: 10.2214/ajr.178.1.1780215 [DOI] [PubMed] [Google Scholar]
- 5.Sumpio BE, Lee T, Blume PA. Vascular evaluation and arterial reconstruction of the diabetic foot. Clin Podiatr Med Surg 2003; 20: 689–708. doi: 10.1016/S0891-8422(03)00088-0 [DOI] [PubMed] [Google Scholar]
- 6.Chomel S, Douek P, Moulin P, Vaudoux M, Marchand B. Contrast-enhanced MR angiography of the foot: anatomy and clinical application in patients with diabetes. AJR Am J Roentgenol 2004; 182: 1435–42. doi: 10.2214/ajr.182.6.1821435 [DOI] [PubMed] [Google Scholar]
- 7.Rubba P, Leccia G, Faccenda F, De Simone B, Carbone L, Pauciullo P, et al. Diabetes mellitus and localizations of obliterating arterial disease of the lower limbs. Angiology 1991; 42: 296–301. doi: 10.1177/000331979104200406 [DOI] [PubMed] [Google Scholar]
- 8.Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am 2002; 40: 1171–92. doi: 10.1016/S0033-8389(02)00036-2 [DOI] [PubMed] [Google Scholar]
- 9.Owen AR, Roditi GH. Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad Med J 2011; 87: 189–98. doi: 10.1136/pgmj.2009.082040 [DOI] [PubMed] [Google Scholar]
- 10.Manzi M, Cester G, Palena LM, Alek J, Candeo A, Ferraresi R. Vascular imaging of the foot: the first step toward endovascular recanalization. Radiographics 2011; 31: 1623–36. doi: 10.1148/rg.316115511 [DOI] [PubMed] [Google Scholar]
- 11.Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis. Radiology 2000; 216: 67–77. doi: 10.1148/radiology.216.1.r00jl0367 [DOI] [PubMed] [Google Scholar]
- 12.Collins R, Cranny G, Burch J, Aguiar-Ibáñez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007; 11: iii–iv, xi–xiii, 1–184. [DOI] [PubMed] [Google Scholar]
- 13.Lapeyre M, Kobeiter H, Desgranges P, Rahmouni A, Becquemin JP, Luciani A. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 2005; 185: 1641–50. doi: 10.2214/AJR.04.1111 [DOI] [PubMed] [Google Scholar]
- 14.Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009; 301: 415–24. doi: 10.1001/jama.301.4.415 [DOI] [PubMed] [Google Scholar]
- 15.Hofmann WJ, Forstner R, Kofler B, Binder K, Ugurluoglu A, Magometschnigg H. Pedal artery imaging—a comparison of selective digital subtraction angiography, contrast enhanced magnetic resonance angiography and duplex ultrasound. Eur J Vasc Endovasc Surg 2002; 24: 287–92. doi: 10.1053/ejvs.2002.1730 [DOI] [PubMed] [Google Scholar]
- 16.Andreisek G, Pfammatter T, Goepfert K, Nanz D, Hervo P, Koppensteiner R, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology 2007; 242: 610–20. doi: 10.1148/radiol.2422051111 [DOI] [PubMed] [Google Scholar]
- 17.Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004; 27: 1458–86. doi: 10.2337/diacare.27.6.1458 [DOI] [PubMed] [Google Scholar]
- 18.Idiculla J, Shirazi N, Opacka-Juffry J, Ganapathi. Diabetic amyotrophy: a brief review. Natl Med J India 2004; 17: 200–2. [PubMed] [Google Scholar]
- 19.Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med 2003; 37: 30–5. doi: 10.1136/bjsm.37.1.30 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Thawait SK, Chaudhry V, Thawait GK, Wang KC, Belzberg A, Carrino JA, et al. High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol 2011; 32: 1365–72. doi: 10.3174/ajnr.A2257 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Chhabra A, Lee PP, Bizzell C, Soldatos T. 3 Tesla MR neurography—technique, interpretation, and pitfalls. Skeletal Radiol 2011; 40: 1249–60. doi: 10.1007/s00256-011-1183-6 [DOI] [PubMed] [Google Scholar]
- 22.Chhabra A, Andreisek G, Soldatos T, Wang KC, Flammang AJ, Belzberg AJ, et al. MR neurography: past, present, and future. AJR Am J Roentgenol 2011; 197: 583–91. doi: 10.2214/AJR.10.6012 [DOI] [PubMed] [Google Scholar]
- 23.Pham M, Oikonomou D, Bäumer P, Bierhaus A, Heiland S, Humpert PM, et al. Proximal neuropathic lesions in distal symmetric diabetic polyneuropathy: findings of high-resolution magnetic resonance neurography. Diabetes Care 2011; 34: 721–3. doi: 10.2337/dc10-1491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Brash PD, Foster J, Vennart W, Anthony P, Tooke JE. Magnetic resonance imaging techniques demonstrate soft tissue damage in the diabetic foot. Diabet Med 1999; 16: 55–61. doi: 10.1046/j.1464-5491.1999.00005.x [DOI] [PubMed] [Google Scholar]
- 25.Cheung YY, Doyley M, Miller TB, Kennedy F, Lynch F, Jr, Wrobel JS, et al. Magnetic resonance elastography of the plantar fat pads: preliminary study in diabetic patients and asymptomatic volunteers. J Comput Assist Tomogr 2006; 30: 321–6. doi: 10.1097/00004728-200603000-00031 [DOI] [PubMed] [Google Scholar]
- 26.Bus SA, Maas M, Cavanagh PR, Michels RP, Levi M. Plantar fat-pad displacement in neuropathic diabetic patients with toe deformity: a magnetic resonance imaging study. Diabetes Care 2004; 27: 2376–81. doi: 10.2337/diacare.27.10.2376 [DOI] [PubMed] [Google Scholar]
- 27.Chatha DS, Cunningham PM, Schweitzer ME. MR imaging of the diabetic foot: diagnostic challenges. Radiol Clin North Am 2005; 43: 747–59, ix. doi: 10.1016/j.rcl.2005.02.008 [DOI] [PubMed] [Google Scholar]
- 28.Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy-current standards. Diabetes Metab Res Rev 2008; 24(Suppl. 1): S58–61. doi: 10.1002/dmrr.846 [DOI] [PubMed] [Google Scholar]
- 29.Ledermann HP, Morrison WB, Schweitzer ME. MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis. Radiology 2002; 223: 747–55. doi: 10.1148/radiol.2233011279 [DOI] [PubMed] [Google Scholar]
- 30.Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996; 13: 979–82. doi: [DOI] [PubMed] [Google Scholar]
- 31.Cavanagh PR, Ulbrecht JS, Caputo GM. New developments in the biomechanics of the diabetic foot. Diabetes Metab Res Rev 2000; 16(Suppl. 1): S6–10. [DOI] [PubMed] [Google Scholar]
- 32.Russell JM, Peterson JJ, Bancroft LW. MR imaging of the diabetic foot. Magn Reson Imaging Clin N Am 2008; 16: 59–70, vi. doi: 10.1016/j.mric.2008.02.004 [DOI] [PubMed] [Google Scholar]
- 33.Morrison WB, Schweitzer ME, Bock GW, Mitchell DG, Hume EL, Pathria MN, et al. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging. Radiology 1993; 189: 251–7. doi: 10.1148/radiology.189.1.8204132 [DOI] [PubMed] [Google Scholar]
- 34.Donovan A, Schweitzer ME. Use of MR imaging in diagnosing diabetes-related pedal osteomyelitis. Radiographics 2010; 30: 723–36. doi: 10.1148/rg.303095111 [DOI] [PubMed] [Google Scholar]
- 35.Wilson DJ, Berendt AR. Bone and soft tissue infection. In: Adam A, Dixon AK, eds. Grainger and Allison's diagnostic radiology. Edimburgh, UK: Churchill Livingstone; 2008. pp. 1153–69. [Google Scholar]
- 36.Ledermann HP, Morrison WB, Schweitzer ME. Pedal abscesses in patients suspected of having pedal osteomyelitis: analysis with MR imaging. Radiology 2002; 224: 649–55. doi: 10.1148/radiol.2243011231 [DOI] [PubMed] [Google Scholar]
- 37.Tan PL, Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol 2007; 80: 939–48. doi: 10.1259/bjr/30036666 [DOI] [PubMed] [Google Scholar]
- 38.Turecki MB, Taljanovic MS, Stubbs AY, Graham AR, Holden DA, Hunter TB, et al. Imaging of musculoskeletal soft tissue infections. Skeletal Radiol 2010; 39: 957–71. doi: 10.1007/s00256-009-0780-0 [DOI] [PubMed] [Google Scholar]
- 39.Mautone M, Gray J, Naidoo P. A case of emphysematous osteomyelitis of the midfoot: imaging findings and review of the literature. Case Rep Radiol 2014; 2014: 616184. doi: 10.1155/2014/616184 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Weber MA, Krix M, Delorme S. Quantitative evaluation of muscle perfusion with CEUS and with MR. Eur Radiol 2007; 17: 2663–74. doi: 10.1007/s00330-007-0641-y [DOI] [PubMed] [Google Scholar]
- 41.Donovan A, Schweitzer ME. Current concepts in imaging diabetic pedal osteomyelitis. Radiol Clin North Am 2008; 46: 1105–24, vii. doi: 10.1016/j.rcl.2008.08.004 [DOI] [PubMed] [Google Scholar]
- 42.Söderquist B, Hedström SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis 1986; 18: 305–11. doi: 10.3109/00365548609032341 [DOI] [PubMed] [Google Scholar]
- 43.Roschmann RA, Bell CL. Septic bursitis in immunocompromised patients. Am J Med 1987; 83: 661–5. [DOI] [PubMed] [Google Scholar]
- 44.Butcher JD, Salzman KL, Lillegard WA. Lower extremity bursitis. Am Fam Physician 1996; 53: 2317–24. [PubMed] [Google Scholar]
- 45.Zimmermann B, III, Mikolich DJ, Ho G, Jr. Septic bursitis. Semin Arthritis Rheum 1995; 24: 391–410. doi: 10.1016/S0049-0172(95)80008-5 [DOI] [PubMed] [Google Scholar]
- 46.Ashman CJ, Klecker RJ, Yu JS. Forefoot pain involving the metatarsal region: differential diagnosis with MR imaging. Radiographics 2001; 21: 1425–40. doi: 10.1148/radiographics.21.6.g01nv071425 [DOI] [PubMed] [Google Scholar]
- 47.Cohen SE, Mahul O, Meir R, Rubinow A. Anserine bursitis and non-insulin dependent diabetes mellitus. J Rheumatol 1997; 24: 2162–5. [PubMed] [Google Scholar]
- 48.Alvarez-Nemegyei J. Risk factors for pes anserinus tendinitis/bursitis syndrome: a case control study. J Clin Rheumatol 2007; 13: 63–5. doi: 10.1097/01.rhu.0000262082.84624.37 [DOI] [PubMed] [Google Scholar]
- 49.Unlu Z, Ozmen B, Tarhan S, Boyvoda S, Goktan C. Ultrasonographic evaluation of pes anserinus tendino-bursitis in patients with type 2 diabetes mellitus. J Rheumatol 2003; 30: 352–4. [PubMed] [Google Scholar]
- 50.Cardinal E, Bureau NJ, Aubin B, Chhem RK. Role of ultrasound in musculoskeletal infections. Radiol Clin North Am 2001; 39: 191–201. doi: 10.1016/S0033-8389(05)70272-4 [DOI] [PubMed] [Google Scholar]
- 51.Peterson JJ, Bancroft LW, Kransdorf MJ. Wooden foreign bodies: imaging appearance. AJR Am J Roentgenol 2002; 178: 557–62. doi: 10.2214/ajr.178.3.1780557 [DOI] [PubMed] [Google Scholar]
- 52.Boyse TD, Fessell DP, Jacobson JA, Lin J, van Holsbeeck MT, Hayes CW. US of soft-tissue foreign bodies and associated complications with surgical correlation. Radiographics 2001; 21: 1251–6. doi: 10.1148/radiographics.21.5.g01se271251 [DOI] [PubMed] [Google Scholar]
- 53.Fessell DP, van Holsbeeck MT. Foot and ankle sonography. Radiol Clin North Am 1999; 37: 831–58, x. doi: 10.1016/S0033-8389(05)70131-7 [DOI] [PubMed] [Google Scholar]
- 54.Pineda C, Espinosa R, Pena A. Radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy. Semin Plast Surg 2009; 23: 80–9. doi: 10.1055/s-0029-1214160 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Kapoor A, Page S, Lavalley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 2007; 167: 125–32. doi: 10.1001/archinte.167.2.125 [DOI] [PubMed] [Google Scholar]
- 56.Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis 2008; 47: 519–27. doi: 10.1086/590011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Poirier JY, Garin E, Derrien C, Devillers A, Moisan A, Bourguet P, et al. Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab 2002; 28: 485–90. [PubMed] [Google Scholar]
- 58.Ranachowska C, Lass P, Korzon-Burakowska A, Dobosz M. Diagnostic imaging of the diabetic foot. Nucl Med Rev Cent East Eur 2010; 13: 18–22. [PubMed] [Google Scholar]
- 59.DiGiovanni CW, Patel A, Calfee R, Nickisch F. Osteonecrosis in the foot. J Am Acad Orthop Surg 2007; 15: 208–17. [DOI] [PubMed] [Google Scholar]
- 60.Nguyen VD, Keh RA, Daehler RW. Freiberg's disease in diabetes mellitus. Skeletal Radiol 1991; 20: 425–8. doi: 10.1007/BF00191084 [DOI] [PubMed] [Google Scholar]
- 61.Pappas JN. The musculoskeletal crescent sign. Radiology 2000; 217: 213–14. doi: 10.1148/radiology.217.1.r00oc22213 [DOI] [PubMed] [Google Scholar]
- 62.Pearce DH, Mongiardi CN, Fornasier VL, Daniels TR. Avascular necrosis of the talus: a pictorial essay. Radiographics 2005; 25: 399–410. doi: 10.1148/rg.252045709 [DOI] [PubMed] [Google Scholar]
- 63.Mitchell DG, Rao VM, Dalinka MK, Spritzer CE, Alavi A, Steinberg ME, et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology 1987; 162: 709–15. doi: 10.1148/radiology.162.3.3809484 [DOI] [PubMed] [Google Scholar]
- 64.Zurlo JV. The double-line sign. Radiology 1999; 212: 541–2. doi: 10.1148/radiology.212.2.r99au13541 [DOI] [PubMed] [Google Scholar]
- 65.Umans H, Haramati N, Flusser G. The diagnostic role of gadolinium enhanced MRI in distinguishing between acute medullary bone infarct and osteomyelitis. Magn Reson Imaging 2000; 18: 255–62. doi: 10.1016/S0730-725X(99)00137-X [DOI] [PubMed] [Google Scholar]
- 66.Hara H, Akisue T, Fujimoto T, Kishimoto K, Imabori M, Kishimoto S, et al. Magnetic resonance imaging of medullary bone infarction in the early stage. Clin Imaging 2008; 32: 147–51. doi: 10.1016/j.clinimag.2007.07.005 [DOI] [PubMed] [Google Scholar]
- 67.Rosenberg ZS, Beltran J, Bencardino JT. From the RSNA Refresher Courses. Radiological Society of North America. MR imaging of the ankle and foot. Radiographics 2000; 20: S153–79. doi: 10.1148/radiographics.20.suppl_1.g00oc26s153 [DOI] [PubMed] [Google Scholar]
- 68.Räkel A, Sheehy O, Rahme E, LeLorier J. Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008; 34: 193–205. doi: 10.1016/j.diabet.2007.10.008 [DOI] [PubMed] [Google Scholar]
- 69.Blakytny R, Spraul M, Jude EB. Review: the diabetic bone: a cellular and molecular perspective. Int J Low Extrem Wounds 2011; 10: 16–32. doi: 10.1177/1534734611400256 [DOI] [PubMed] [Google Scholar]
- 70.Roug IK, Pierre-Jerome C. MRI spectrum of bone changes in the diabetic foot. Eur J Radiol 2012; 81: 1625–9. doi: 10.1016/j.ejrad.2011.04.048 [DOI] [PubMed] [Google Scholar]
- 71.Pierre-Jerome C, Reyes EJ, Moncayo V, Chen ZN, Terk MR. MRI of the cuboid bone: analysis of changes in diabetic versus non-diabetic patients and their clinical significance. Eur J Radiol 2012; 81: 2771–5. doi: 10.1016/j.ejrad.2011.10.001 [DOI] [PubMed] [Google Scholar]
- 72.Hedlund LJ, Maki DD, Griffiths HJ. Calcaneal fractures in diabetic patients. J Diabetes Complications 1998; 12: 81–7. doi: 10.1016/S1056-8727(97)00052-4 [DOI] [PubMed] [Google Scholar]
- 73.Athans W, Stephens H. Open calcaneal fractures in diabetic patients with neuropathy: a report of three cases and literature review. Foot Ankle Int 2008; 29: 1049–53. doi: 10.3113/FAI.2008.1049 [DOI] [PubMed] [Google Scholar]
- 74.Holewski JJ, Moss KM, Stess RM, Graf PM, Grunfeld C. Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic. J Rehabil Res Dev 1989; 26: 35–44. [PubMed] [Google Scholar]
- 75.Bus SA, Yang QX, Wang JH, Smith MB, Wunderlich R, Cavanagh PR. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care 2002; 25: 1444–50. doi: 10.2337/diacare.25.8.1444 [DOI] [PubMed] [Google Scholar]
- 76.Bus SA, Maas M, de Lange A, Michels RP, Levi M. Elevated plantar pressures in neuropathic diabetic patients with claw/hammer toe deformity. J Biomech 2005; 38: 1918–25. doi: 10.1016/j.jbiomech.2004.07.034 [DOI] [PubMed] [Google Scholar]
- 77.Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Surg 2008; 25: 17–28, v. doi: 10.1016/j.cpm.2007.10.001 [DOI] [PubMed] [Google Scholar]
- 78.Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. Diabetes Care 2011; 34: 2123–9. doi: 10.2337/dc11-0844 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Jeffcoate W. The causes of the Charcot syndrome. Clin Podiatr Med Surg 2008; 25: 29–42, vi. doi: 10.1016/j.cpm.2007.10.003 [DOI] [PubMed] [Google Scholar]
- 80.Myerson MS, Henderson MR, Saxby T, Short KW. Management of midfoot diabetic neuroarthropathy. Foot Ankle Int 1994; 15: 233–41. doi: 10.1177/107110079401500502 [DOI] [PubMed] [Google Scholar]
- 81.Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 2009; 32: 816–21. doi: 10.2337/dc08-1695 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.van Baal J, Hubbard R, Game F, Jeffcoate W. Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care 2010; 33: 1086–9. doi: 10.2337/dc09-1428 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Loredo RA, Garcia G, Chhaya S. Medical imaging of the diabetic foot. Clin Podiatr Med Surg 2007; 24: 397–424, viii. doi: 10.1016/j.cpm.2007.03.010 [DOI] [PubMed] [Google Scholar]
- 84.Rogers LC, Bevilacqua NJ. The diagnosis of Charcot foot. Clin Podiatr Med Surg 2008; 25: 43–51, vi. doi: 10.1016/j.cpm.2007.10.006 [DOI] [PubMed] [Google Scholar]
- 85.Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 45: 1085–96. doi: 10.1007/s00125-002-0885-7 [DOI] [PubMed] [Google Scholar]
- 86.Rogers LC, Bevilacqua NJ. Imaging of the Charcot foot. Clin Podiatr Med Surg 2008; 25: 263–74, vii. doi: 10.1016/j.cpm.2008.01.002 [DOI] [PubMed] [Google Scholar]
- 87.Clouse ME, Gramm HF, Legg M, Flood T. Diabetic osteoarthropathy. Clinical and roentgenographic observations in 90 cases. Am J Roentgenol Radium Ther Nucl Med 1974; 121: 22–34. doi: 10.2214/ajr.121.1.22 [DOI] [PubMed] [Google Scholar]
- 88.Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972; 51: 191–210. doi: 10.1097/00005792-197205000-00006 [DOI] [PubMed] [Google Scholar]
- 89.Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetologia 2004; 47: 1488–92. doi: 10.1007/s00125-004-1477-5 [DOI] [PubMed] [Google Scholar]
- 90.Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am 1990; 72: 749–56. [PubMed] [Google Scholar]
- 91.Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med 2005; 22: 1707–12. doi: 10.1111/j.1464-5491.2005.01677.x [DOI] [PubMed] [Google Scholar]
- 92.Chantelau E, Poll LW. Evaluation of the diabetic charcot foot by MR imaging or plain radiography—an observational study. Exp Clin Endocrinol Diabetes 2006; 114: 428–31. doi: 10.1055/s-2006-924229 [DOI] [PubMed] [Google Scholar]
- 93.Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology 2006; 238: 622–31. doi: 10.1148/radiol.2382041393 [DOI] [PubMed] [Google Scholar]
- 94.Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995; 273: 721–3. doi: 10.1001/jama.1995.03520330051036 [DOI] [PubMed] [Google Scholar]
- 95.Lavery LA, Armstrong DG, Peters EJ, Lipsky BA. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care 2007; 30: 270–4. doi: 10.2337/dc06-1572 [DOI] [PubMed] [Google Scholar]
- 96.Ergen FB, Sanverdi DE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle 2013; 4. doi: 10.3402/dfa.v4i0.21884 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Karchevsky M, Schweitzer ME, Morrison WB, Parellada JA. MRI findings of septic arthritis and associated osteomyelitis in adults. AJR Am J Roentgenol 2004; 182: 119–22. doi: 10.2214/ajr.182.1.1820119 [DOI] [PubMed] [Google Scholar]
- 98.Graif M, Schweitzer ME, Deely D, Matteucci T. The septic versus nonseptic inflamed joint: MRI characteristics. Skeletal Radiol 1999; 28: 616–20. doi: 10.1007/s002560050562 [DOI] [PubMed] [Google Scholar]
- 99.Andersen H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 2004; 27: 2382–5. doi: 10.2337/diacare.27.10.2382 [DOI] [PubMed] [Google Scholar]
- 100.Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 1997; 40: 1062–9. doi: 10.1007/s001250050788 [DOI] [PubMed] [Google Scholar]
- 101.Robertson DD, Mueller MJ, Smith KE, Commean PK, Pilgram T, Johnson JE. Structural changes in the forefoot of individuals with diabetes and a prior plantar ulcer. J Bone Joint Surg Am 2002; 84-A: 1395–404. [DOI] [PubMed] [Google Scholar]
- 102.Angervall L, Stener B. Tumoriform focal muscular degeneration in two diabetic patients. Diabetologia 1965; 1: 39–42. doi: 10.1007/BF01338714 [DOI] [Google Scholar]
- 103.Chester CS, Banker BQ. Focal infarction of muscle in diabetics. Diabetes Care 1986; 9: 623–30. doi: 10.2337/diacare.9.6.623 [DOI] [PubMed] [Google Scholar]
- 104.Huang BK, Monu JU, Doumanian J. Diabetic myopathy: MRI patterns and current trends. AJR Am J Roentgenol 2010; 195: 198–204. doi: 10.2214/AJR.09.2494 [DOI] [PubMed] [Google Scholar]
- 105.Glauser SR, Glauser J, Hatem SF. Diabetic muscle infarction: a rare complication of advanced diabetes mellitus. Emerg Radiol 2008; 15: 61–5. doi: 10.1007/s10140-007-0629-6 [DOI] [PubMed] [Google Scholar]
- 106.Sharma P, Mangwana S, Kapoor RK. Diabetic muscle infarction: atypical MR appearance. Skeletal Radiol 2000; 29: 477–80. doi: 10.1007/s002560000246 [DOI] [PubMed] [Google Scholar]
- 107.Jelinek JS, Murphey MD, Aboulafia AJ, Dussault RG, Kaplan PA, Snearly WN. Muscle infarction in patients with diabetes mellitus: MR imaging findings. Radiology 1999; 211: 241–7. doi: 10.1148/radiology.211.1.r99ap44241 [DOI] [PubMed] [Google Scholar]
- 108.Delaney-Sathy LO, Fessell DP, Jacobson JA, Hayes CW. Sonography of diabetic muscle infarction with MR imaging, CT, and pathologic correlation. AJR Am J Roentgenol 2000; 174: 165–9. doi: 10.2214/ajr.174.1.1740165 [DOI] [PubMed] [Google Scholar]
- 109.Marath H, Yates M, Lee M, Dhatariya K. Pyomyositis. J Diabetes Complications 2011; 25: 346–8. doi: 10.1016/j.jdiacomp.2010.09.002 [DOI] [PubMed] [Google Scholar]
- 110.Chiedozi LC. Pyomyositis. Review of 205 cases in 112 patients. Am J Surg 1979; 137: 255–9. [DOI] [PubMed] [Google Scholar]
- 111.Struk DW, Munk PL, Lee MJ, Ho SG, Worsley DF. Imaging of soft tissue infections. Radiol Clin North Am 2001; 39: 277–303. doi: 10.1016/S0033-8389(05)70278-5 [DOI] [PubMed] [Google Scholar]
- 112.de Oliveira RR, Lemos A, de Castro Silveira PV, da Silva RJ, de Moraes SR. Alterations of tendons in patients with diabetes mellitus: a systematic review. Diabet Med 2011; 28: 886–95. doi: 10.1111/j.1464-5491.2010.03197.x [DOI] [PubMed] [Google Scholar]
- 113.Bolton NR, Smith KE, Pilgram TK, Mueller MJ, Bae KT. Computed tomography to visualize and quantify the plantar aponeurosis and flexor hallucis longus tendon in the diabetic foot. Clin Biomech (Bristol, Avon) 2005; 20: 540–6. doi: 10.1016/j.clinbiomech.2004.12.007 [DOI] [PubMed] [Google Scholar]
- 114.Batista F, Nery C, Pinzur M, Monteiro AC, de Souza EF, Felippe FH, et al. Achilles tendinopathy in diabetes mellitus. Foot Ankle Int 2008; 29: 498–501. doi: 10.3113/FAI.2008.0498 [DOI] [PubMed] [Google Scholar]
- 115.Papanas N, Courcoutsakis N, Papatheodorou K, Daskalogiannakis G, Maltezos E, Prassopoulos P. Achilles tendon volume in type 2 diabetic patients with or without peripheral neuropathy: MRI study. Exp Clin Endocrinol Diabetes 2009; 117: 645–8. doi: 10.1055/s-0029-1224121 [DOI] [PubMed] [Google Scholar]
- 116.D'Ambrogi E, Giacomozzi C, Macellari V, Uccioli L. Abnormal foot function in diabetic patients: the altered onset of Windlass mechanism. Diabet Med 2005; 22: 1713–19. doi: 10.1111/j.1464-5491.2005.01699.x [DOI] [PubMed] [Google Scholar]
- 117.Campbell RS, Grainger AJ. Current concepts in imaging of tendinopathy. Clin Radiol 2001; 56: 253–67. doi: 10.1053/crad.2000.0653 [DOI] [PubMed] [Google Scholar]
- 118.Bleakney RR, White LM. Imaging of the Achilles tendon. Foot Ankle Clin 2005; 10: 239–54. doi: 10.1016/j.fcl.2005.01.006 [DOI] [PubMed] [Google Scholar]
- 119.Schweitzer ME, Karasick D. MR imaging of disorders of the posterior tibialis tendon. AJR Am J Roentgenol 2000; 175: 627–35. doi: 10.2214/ajr.175.3.1750627 [DOI] [PubMed] [Google Scholar]
- 120.Ledermann HP, Morrison WB, Schweitzer ME, Raikin SM. Tendon involvement in pedal infection: MR analysis of frequency, distribution, and spread of infection. AJR Am J Roentgenol 2002; 179: 939–47. doi: 10.2214/ajr.179.4.1790939 [DOI] [PubMed] [Google Scholar]




















